Loading...
D

Definitive Healthcare Corp
NASDAQ:DH

Watchlist Manager
Definitive Healthcare Corp
NASDAQ:DH
Watchlist
Price: 11.37 USD +6.36% Market Closed
Updated: Dec 1, 2022

Intrinsic Value

The intrinsic value of one DH stock under the Base Case scenario is 9.58 USD. Compared to the current market price of 11.37 USD, Definitive Healthcare Corp is Overvalued by 16%.

The Intrinsic Value is calculated as the average of the two valuation methods:

DH Intrinsic Value
Base Case
9.58 USD
Overvaluation 16%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Fundamental Analysis

DH Profitability Score
Profitability Due Diligence

Definitive Healthcare Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative Operating Income
Negative Net Income
Negative 3-Year Average ROIC
45/100
Profitability
Score

Definitive Healthcare Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

DH Solvency Score
Solvency Due Diligence

Definitive Healthcare Corp's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Negative Net Debt
Long-Term Liabilities
46/100
Solvency
Score

Definitive Healthcare Corp's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
79%
Gross Margin
-17%
Operating Margin
-13%
Net Margin
19%
FCF Margin
-3%
ROE
-2%
ROIC
Other

DH Capital Structure
Definitive Healthcare Corp

Market Capitalization 1.2B USD
Total Debt 259M USD
Minority Interest 545M USD
Preferred Equity 0 USD
Cash and Equivalents 229M USD
Short-Term Investments 121M USD
Enterprise Value 1.6B USD

Wall St
Price Targets

DH Price Targets Summary
Definitive Healthcare Corp

Wall Street analysts forecast DH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DH is 26.89 USD with a low forecast of 18.18 USD and a high forecast of 33.6 USD.

Lowest
Price Target
18.18 USD
60% Upside
Average
Price Target
26.89 USD
137% Upside
Highest
Price Target
33.6 USD
196% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

DH Competitors
Definitive Healthcare Corp

DH Suppliers & Customers
Definitive Healthcare Corp

There is no information about
Definitive Healthcare Corp
key suppliers

Definitive Healthcare Corp has 9 key customers from 5 countries and 5 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

DH Shareholders
Major Shareholders

Insiders own a significant part of the company.

Top 25 shareholders own 318.04% of the company. Insiders own 226.26%. The biggest insider is Young Lauren (Director), who owns 59.47% of Definitive Healthcare Corp.

Insiders
226.26%
Institutions
100.12%
Other
-226.38%
Insiders
226.26%
Young Lauren
Director
Ownership
59.4725%
Market Value
711M USD
Shares
62 493 676
Egan Christopher
Director
Ownership
59.4725%
Market Value
711M USD
Shares
62 493 676
Advent International Corp/Ma
Director, 10 percent owner
Ownership
59.4725%
Market Value
711M USD
Shares
62 493 676
Sea Vii Management, Llc
Director, 10 percent owner
Ownership
44.2146%
Market Value
528M USD
Shares
46 460 659
Krantz Jason Ronald
Other
Ownership
1.3627%
Market Value
16.3M USD
Shares
1 431 977
Musslewhite Robert W
Chief Executive Officer
Ownership
0.9478%
Market Value
11.3M USD
Shares
995 997
Maack Jonathan
President
Ownership
0.5199%
Market Value
6.2M USD
Shares
546 303
Mirisola Joseph Gianni
Chief Revenue Officer
Ownership
0.4851%
Market Value
5.8M USD
Shares
509 748
Mitchell Christopher
Director
Ownership
0.0654%
Market Value
782k USD
Shares
68 748
Booth Richard Douglas
Chief Financial Officer
Ownership
0.0571%
Market Value
682k USD
Shares
59 974
Shamsuddin Kate Marie
Chief Product Officer
Ownership
0.0502%
Market Value
600k USD
Shares
52 767
Hamood Samuel A
Director
Ownership
0.0491%
Market Value
586k USD
Shares
51 582
Chilukuri Sastry
Director
Ownership
0.0253%
Market Value
302k USD
Shares
26 588
Samuels David M
Chief Legal Officer
Ownership
0.022%
Market Value
263k USD
Shares
23 167
Winters Kathleen A
Director
Ownership
0.0186%
Market Value
223k USD
Shares
19 586
Larsen Jill
Director
Ownership
0.0138%
Market Value
165k USD
Shares
14 545
Winn David Randall
Director
Ownership
0.0116%
Market Value
139k USD
Shares
12 239
Institutions
100.12%
Back

DH Insider Trading
Buy and sell transactions by insiders

Definitive Healthcare Corp insiders have sold more shares than they have bought in the past 12 months.

During the last 12 months Definitive Healthcare Corp insiders bought 5.2M USD , and sold 56.5M USD worth of shares. The last transaction was made on Dec 1, 2022 by Krantz Jason Ronald (Other), who bought 5.2M USD worth of DH shares.

Sold
0-3
months
0 USD
0
3-6
months
56.1M USD
2
6-9
months
382k USD
2
9-12
months
0 USD
0
Bought
0-3
months
1
5.2M USD
3-6
months
0
0 USD
6-9
months
1
50k USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
5.2M USD
5.2M
6 Months
56.1M USD
5.2M USD
-50.9M
9 Months
56.5M USD
5.2M USD
-51.2M
12 Months
56.5M USD
5.2M USD
-51.2M
Purchases
2
Sales
6
Why is insider trading important?

Shareholder Return

DH Price
Definitive Healthcare Corp

1M 1M
-27%
6M 6M
-41%
1Y 1Y
-60%
3Y 3Y
-74%
5Y 5Y
-74%
Annual Price Range
11.37
52w Low
10.14
52w High
32.08
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -79%

Company Profile

Definitive Healthcare Corp

Country

United States of America

Industry

Health Care

Market Cap

1.2B USD

Dividend Yield

0%

Description

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 676 full-time employees. The company went IPO on 2021-09-15. The firm provides solutions through its software-as-a-service (SaaS) platform, which provides information on healthcare providers and their activities to help its customers optimize from product development to go-to-market planning and sales and marketing execution. Its platform offers Artificial Intelligence (AI) engine and Front-end SaaS platform. The firm's platform is embedded with deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The firm provides services across biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers and other diversified companies.

Contact

MASSACHUSETTS
Framingham
550 Cochituate Road
+15087204224.0
https://www.definitivehc.com/

IPO

2021-09-15

Employees

676

Officers

Founder & Exec. Chairman
Mr. Jason Ronald Krantz
CEO & Director
Mr. Robert W. Musslewhite J.D.
Chief Financial Officer
Mr. Richard Douglas Booth
Chief Technology Officer
Mr. Scott Oberlink
Chief Legal Officer
Mr. David M. Samuels
Chief Marketing Officer
Mr. Justin A. Steinman
Show More
Chief Revenue Officer
Mr. Joseph Gianni Mirisola
Chief Product Officer
Ms. Kate Marie Shamsuddin Jensen
Chief Growth Officer
Mr. David Kronfeld
Chief Talent Officer
Mr. Tom Penque
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one DH stock?

The intrinsic value of one DH stock under the Base Case scenario is 9.58 USD.

Is DH stock undervalued or overvalued?

Compared to the current market price of 11.37 USD, Definitive Healthcare Corp is Overvalued by 16%.